IRCCS Istituto Giannina Gaslini, Pediatric Rheumatology International Trials Organisation (PRINTO)

01/02/2024
01/02/2024
Institution
Not-for-profit
Download as PDF
Institution identification

Institution ID

3331212

Institution full name and acronym

IRCCS Istituto Giannina Gaslini, Pediatric Rheumatology International Trials Organisation (PRINTO)

Institution countries

Italy

Type of institution

Not-for-profit

Institution role

Data holder

Institution website

ENCePP partner

No
Institution description
Pediatric hospital
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact details

Studies conducted by the institution

A non-interventional, post authorization safety study (PASS) to evaluate the safety of Kineret in the treatment of Cryopyrin Associated Periodic Syndromes (CAPS) in routine clinical care with regard to serious infections, malignancies, injection site reactions, allergic reactions and medication errors, including re-use of syringe. Sobi.Anakin-201 (PASS Kineret CAPS)
A non-interventional, post-authorization safety study (PASS) to evaluate long-term safety of anakinra (Kineret®) in patients with systemic juvenile idiopathic arthritis
Pharmacovigilance In Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents And/Or Methotrexate. A Pediatric Rheumatology International Trials Organisation (PRINTO)/Pediatric Rheumatology European Society (PRES) Registry (Pharmachild JIA registry)